Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Plasma and tumor caveolin-1 (Cav-1) are linked with disease progression in prostate cancer. Here we report that metabolomic profiling of longitudinal plasmas from a prospective cohort of 491 active surveillance (AS) participants indicates prominent elevations in plasma sphingolipids in AS progressor...

Descripción completa

Detalles Bibliográficos
Autores principales: Vykoukal, Jody, Fahrmann, Johannes F., Gregg, Justin R., Tang, Zhe, Basourakos, Spyridon, Irajizad, Ehsan, Park, Sanghee, Yang, Guang, Creighton, Chad J., Fleury, Alia, Mayo, Jeffrey, Paulucci-Holthauzen, Adriana, Dennison, Jennifer B., Murage, Eunice, Peterson, Christine B., Davis, John W., Kim, Jeri, Hanash, Samir, Thompson, Timothy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453025/
https://www.ncbi.nlm.nih.gov/pubmed/32855410
http://dx.doi.org/10.1038/s41467-020-17645-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453025/
https://www.ncbi.nlm.nih.gov/pubmed/32855410
http://dx.doi.org/10.1038/s41467-020-17645-z

Ejemplares similares